Clinical Trials on Healthy Volunteer Smokers in United Kingdom

Total 8804 results

Takeda

Completed

TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability Study

Healthy Volunteers

United Kingdom
ProtAffin Biotechnologie AG

Terminated

A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401

Healthy Volunteers

United Kingdom
AstraZeneca

Terminated

Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers

Healthy Volunteers

United Kingdom
AstraZeneca

Terminated

Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers

Healthy Volunteers

United Kingdom
Light Chain Bioscience - Novimmune SA

Completed

First in Human Study of NI-0701 in Healthy Volunteers

Healthy Volunteers

United Kingdom
AnaMar AB

Terminated

AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects

Healthy Volunteers

United Kingdom
Imperial College London

Recruiting

Closed-loop Control of Penicillin Delivery (CLCPD)

Healthy Volunteers

United Kingdom
Eisai Limited

Completed

A Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of Carbon-14 (14C)E7386 in Healthy Male Participants

Healthy Volunteers

United Kingdom
Bristol-Myers Squibb

Completed

A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants

Healthy Volunteers

United Kingdom
Xenon Pharmaceuticals Inc.

Completed

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.

Healthy Volunteers

United Kingdom
Incyte Corporation

Completed

A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB086550

Healthy Volunteers

United Kingdom
Eisai Limited

Completed

A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants

Healthy Volunteers

United Kingdom
Imperial College London

Completed

Effect of Sucrose on Liver Fat

Healthy Volunteers

United Kingdom
Imperial College London
Malaysia Palm Oil Board

Completed

Effect of Palm Olein Intake on Lipid Profile and Fat Deposition (PalmOil)

Healthy Volunteers

United Kingdom
Pierre Fabre Dermatology

Withdrawn

Bioavailability Pilot Study of Versus W0035 Versus Stromectol

Healthy Volunteers

United Kingdom
ASLAN Pharmaceuticals

Completed

Open, Single-dose/-Period Study to Assess Mass Balance Recovery, Metabolite Profile/Identification of 14C-Varlitinib

Healthy Volunteers

United Kingdom
Eli Lilly and Company

Completed

A Study of LY3016859 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Queen Mary University of London
Metagenics, Inc.

Unknown

SPM Regulation by Fish Oil Supplements in Healthy Volunteers

Healthy Volunteers

United Kingdom
Egalet Ltd

Completed

Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers

Healthy Volunteers

United Kingdom
Egalet Ltd

Completed

Study to Determine the Tolerability, Safety and Pharmacokinetics of Ketorolac Tromethamine by Intranasal Administration in Healthy Volunteers

Healthy Volunteers

United Kingdom
UCB Biopharma S.P.R.L.

Completed

A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Celgene

Completed

A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults

Healthy Volunteers

United Kingdom
Astellas Pharma Europe B.V.

Completed

A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects

Healthy Volunteers

United Kingdom
Ardelyx

Completed

AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study

Healthy Volunteers

United Kingdom
Medicines for Malaria Venture

Completed

A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route

Healthy Volunteers

United Kingdom
UCB Celltech
Parexel

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy Subjects

Healthy Volunteers

United Kingdom
University of Manchester

Completed

Sunlight Exposure and Vitamin D Status of Children of South Asian Ethnicity Living in the UK

Healthy Volunteers

United Kingdom
Janssen Cilag N.V./S.A.

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants

Healthy Volunteers

United Kingdom
Duke University
National Institutes of Health (NIH)

Completed

Memory and Picture Viewing Study (MPVS)

Healthy | Brain Reactivity of Non-smokers Undergoing fMRI Scanning

United States
Biogen

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, With Target Occupancy Study of BIIB113 in Healthy Participants

Healthy Volunteer

United Kingdom, Sweden
Supernus Pharmaceuticals, Inc.

Completed

Mass Balance Study of NV-5138 in Healthy Male Subjects

Healthy Volunteers

United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects

Healthy Volunteers

United Kingdom
Enterome
Quotient Clinical

Completed

First-in-Human Single and Multiple Dose of EB8018

Healthy Volunteers

United Kingdom
Momenta Pharmaceuticals, Inc.
Mylan Inc.

Completed

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

Healthy Volunteers

United Kingdom
Eli Lilly and Company

Completed

A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants

Healthy Volunteers

United Kingdom
Afferent Pharmaceuticals, Inc.

Completed

A Pharmacokinetics Study of AF-130 in Healthy Subjects

Healthy Volunteers

United Kingdom
UCB Pharma SA

Completed

Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects

Healthy Volunteers

United Kingdom
AstraZeneca

Completed

AZD5672 Absolute Bioavailability Study

Healthy Volunteers

United Kingdom
University of Glasgow
NHS Greater Glasgow and Clyde

Recruiting

Deriving Cardiac Reference Ranges at 3.0Tesla in Healthy Volunteers (DECADENT-HV)

Healthy Volunteers

United Kingdom
Kadmon Corporation, LLC
Quotient Sciences

Completed

A Phase I Study to Evaluate the Taste of Belumosudil Oral Suspensions & Assess Relative Bioavailability

Healthy Volunteers

United Kingdom
Chugai Pharmaceutical

Completed

Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371

Healthy Volunteers

United Kingdom
Innovation Pharmaceuticals, Inc.

Completed

A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers

Healthy Volunteers

United Kingdom
Corino Therapeutics, Inc.
Quotient Sciences

Completed

A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone

Healthy Volunteers

United Kingdom
University of Nottingham

Completed

The Relationship Between Cardiac Output and Microvascular Visceral Blood Flow

Healthy Volunteers

United Kingdom
UCB Pharma

Completed

Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects

Healthy Volunteers

United Kingdom
Pulmagen Therapeutics

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ADC3680B in Healthy Volunteers

Healthy Volunteers

United Kingdom
Swedish Orphan Biovitrum

Completed

First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy Volunteers

Healthy Volunteers

United Kingdom
Applied Molecular Transport

Completed

SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects

Healthy Volunteers

United Kingdom
Sandoz

Completed

In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy Subjects

Healthy Volunteers

United Kingdom
Senju Pharmaceutical Co., Ltd.
Quotient Sciences

Completed

Single Dose ADME Study of [14C]SJP-0008 in Healthy Male Subjects

Healthy Volunteers

United Kingdom

3

Subscribe